Interim PET/CT based on visual and semiquantitative analysis predicts survival in patients with diffuse large B‐cell lymphoma

Interim PET/CT based on visual and semiquantitative analysis predicts survival in patients with diffuse large B‐cell lymphoma

Abstract Purpose The role of interim 18F‐FDG PET/CT (iPET/CT) in diffuse large B‐cell lymphoma (DLBCL) remains controversial. The purpose of this study was to assess the prognostic value of iPET/CT in patients with newly diagnosed DLBCL according to visual and semiquantitative interpretation methods...

Full description

Bibliographic Details
Main Authors:	Xiaoqian Li, Xun Sun, Juan Li, Zijian Liu, Mi Mi, Fang Zhu, Gang Wu, Xiaoli Lan, Liling Zhang
Format:	Article
Language:	English
Published:	Wiley 2019-09-01
Series:	Cancer Medicine
Subjects:	deauville 5‐point scale diffuse large B‐cell lymphoma interim PET/CT SUVmax reduction tumor burden
Online Access:	https://doi.org/10.1002/cam4.2404

Similar Items

Deauville score versus ratio Deauville score in the interpretation of interim 18F-FDG PET-CT and in prediction of outcome in children with FDG-avid extra-nodal lymphomas
by: Hadeer Yousef Elhamady, et al.
Published: (2022-10-01)

Prognostic Value of FDG PET/CT in Patients with Nodal Peripheral T-Cell Lymphoma
by: Woo Hee Choi, et al.
Published: (2023-09-01)

Impact of Reduced Image Noise on Deauville Scores in Patients with Lymphoma Scanned on a Long-Axial Field-of-View PET/CT-Scanner
by: Kirsten Korsholm, et al.
Published: (2023-03-01)

Sarcoid-Like Reaction in Non-Hodgkin’s Lymphoma—A Diagnostic Challenge for Deauville Scoring on <sup>18</sup>F-FDG PET/CT Imaging
by: Michael Winkelmann, et al.
Published: (2021-05-01)

Value of 18F-FDG PET/CT Parameters and Deauville 5-point Scoring in Efficacy Evaluation and Prognosis Prediction of Diffuse Large B Cell Lymphoma Patients
by: YANG Ming, et al.
Published: (2020-08-01)

FDG‐PET/CT‐guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma
by: Aino Rajamäki, et al.
Published: (2023-01-01)

Early Interim Chemotherapy Response Evaluation by F-18 FDG PET/CT in Diffuse Large B Cell Lymphoma
by: Hye Lim Park, et al.
Published: (2020-11-01)

The effect of reduced scan time on response assessment FDG-PET/CT imaging using Deauville score in patients with lymphoma
by: Charlotte Hornnes, et al.
Published: (2021-01-01)

The use of a proposed updated EARL harmonization of 18F-FDG PET-CT in patients with lymphoma yields significant differences in Deauville score compared with current EARL recommendations
by: John Ly, et al.
Published: (2019-07-01)

Assessing the intracranial metabolic score as a novel prognostic tool in primary CNS lymphoma with end of induction-chemotherapy 18F-FDG PET/CT and PET/MR
by: Yiwen Mo, et al.
Published: (2024-11-01)

Risk Stratification Of Diffuse Large B-Cell Lymphoma With Interim PET/CT By Combining Deauville Scores And International Prognostic Index
by: Sun H, et al.
Published: (2019-11-01)

Multiple myeloma: characterization of patients through the analysis of semiquantitative parameters with 18F-FDG PET
by: Maria Silvia De Feo, et al.
Published: (2023-06-01)

Semiquantitative 2-[18F]FDG PET/CT-based parameters role in lymphoma
by: Domenico Albano, et al.
Published: (2024-12-01)

Prognostic value and clinical impact of 18FDG-PET in the management of children with Burkitt lymphoma after induction chemotherapy.
by: clement eBailly, et al.
Published: (2014-12-01)

Correlation Between Ki67 Expression and 18F-FDG PET/CT SUVmax in Patient with Diffuse Large B-cell Lymphoma and Their Application in Therapeutic Effect Evaluation
by: YANG Ming, et al.
Published: (2018-12-01)

Influence of metabolic tumor burden on reference tissues’ standardized uptake values in 18F-FDG PET/CT sequential imaging
by: Ahmed Badawy, et al.
Published: (2023-11-01)

Baseline [18F]FDG PET/CT radiomics for predicting interim efficacy in follicular lymphoma treated with first-line R-CHOP
by: Zeying Wen, et al.
Published: (2025-01-01)

Clinical Significance of Incidental 18-FDG Uptake in Nasopharynx on PET/CT Scanning
by: İmdat Yüce, et al.
Published: (2019-11-01)

Prognostic value of pre-treatment FDG PET/CT SUVmax for metastatic lesions in de novo metastatic nasopharyngeal carcinoma following chemotherapy and locoregional radiotherapy
by: Wenbin Yan, et al.
Published: (2023-02-01)

Prognostic value of 18F-FDG PET/CT SUVmax before R-CHOP treatment for diffuse large B cell lymphoma: an analysis of 76 cases
by: LEI Chengming, et al.
Published: (2020-09-01)

Analysis of Positive Results of <sup>18</sup>F-FDG PET/CT Imaging after Hematopoietic Stem Cell Transplantation in Lymphoma
by: Na Dai, et al.
Published: (2023-06-01)

Construction and validation of an 18F-FDG-PET/CT-based prognostic model to predict progression-free survival in newly diagnosed multiple myeloma patients
by: Xiaoqing Dong, et al.
Published: (2024-12-01)

Significance of metabolic parameters and biochemical indexes of 18F-FDG PET/CT in the mid-term evaluation and prognosis of diffuse large B-cell lymphoma
by: Zhang Fan, Zhang Guoxu, Liu Xiuting, Wang Jigang, Liu Yanqin, Tong Danjiang, Liu Jinghua, Zhou Fan
Published: (2022-03-01)

DARS2 overexpression is associated with PET/CT metabolic parameters and affects glycolytic activity in lung adenocarcinoma
by: Xu-Sheng Liu, et al.
Published: (2023-08-01)

Classical Hodgkin Lymphoma: A Joint Clinical and PET Model to Predict Poor Responders at Interim Assessment
by: Elizabeth Katherine Anna Triumbari, et al.
Published: (2022-09-01)

Standardized classification schemes in reporting oncologic PET/CT
by: Vanessa Murad, et al.
Published: (2023-01-01)

Hounsfield unit value has null effect on thyroid nodules at 18F-FDG PET/CT scans
by: Filiz Eksi Haydardedeoglu, et al.

Response assessment in lymphoma with PET/CT
by: J S Moller, et al.
Published: (2008-03-01)

Corrigendum: Standardized classification schemes in reporting oncologic PET/CT
by: Vanessa Murad, et al.
Published: (2023-11-01)

PET/CT in initial staging and therapy response assessment of lymphoma
by: Nagham Nabil Omar, et al.
Published: (2016-12-01)

The role of FDG-PET in Hodgkin lymphoma
by: Edyta Subocz, et al.
Published: (2017-06-01)

Unusual presentation of adrenal lymphoma observed with PET-CT
by: Zeynep Gözde Özkan, et al.
Published: (2011-12-01)

Is local review of positron emission tomography scans sufficient in diffuse large B‐cell lymphoma clinical trials? A CALGB 50303 analysis
by: Pallawi Torka, et al.
Published: (2023-04-01)

Clinical usefulness of PET-CT in staging, evaluation of treatment response and restaging of thoracic lymphoma
by: Ahmed Elsammak
Published: (2017-12-01)

Analysis of redox status and HDL subclasses in patients with lymphoma and the associations with FDG-PET/CT findings
by: Bosa Mirjanic-Azaric, et al.
Published: (2023-10-01)

Evaluating the value of 18F-PSMA-1007 PET/CT in the detection and identification of prostate cancer using histopathology as the standard
by: Liang Luo, et al.
Published: (2023-11-01)

Neurolymphomatosis: Unusual Extranodal Involvement Pattern on 18F-FDG PET/CT in a Non-Hodgkin Lymphoma Recurrence
by: Marcos Pretto Mosmann, et al.
Published: (2011-04-01)

Staging Gallium-68 DOTATATE PET/CT Imaging in Neuroendocrine Tumors: Relationship between Measured SUVmax of the Primary Tumor and the Pathological Grade and Ki-67 Proliferation Index
by: Emin Büyüktalancı, et al.
Published: (2025-02-01)

Prognostic values of baseline, interim and end-of therapy 18F-FDG PET/CT in patients with follicular lymphoma
by: Zhou Y, et al.
Published: (2019-07-01)

Avaliação do SUVmax na captação do [68Ga]Ga-DOTA-TATE PET/CT em doentes com tumores neuroendócrinos: revisão de literatura
by: Carolina Maricato, et al.
Published: (2022-11-01)